Skip to main content
Clinical Trials/NCT01211223
NCT01211223CompletedPhase 4

Effects of the Variation in the Time of Systemic Administration of Metronidazole and Amoxicillin Associated to the Non-surgical Therapy of Chronic Periodontitis.

University of Chile1 site in 1 country42 target enrollmentStarted: January 2010Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
42
Locations
1
Primary Endpoint
- Mean change in clinical attachment level (CAL)

Study Overview

Brief Summary

• Background: Peridontitis is a group of diseases with complex bacterial etiology that affects a large proportion of the Chilean and worldwide population. Its treatment, based on an anti-infective mechanical therapy including scaling and root planning procedures, has been highly effective in numerous short and long term clinical trials. The use of adjunctive systemic antibiotics has shown significant improvements in the initial therapy results of specific periodontal disease types or patient profiles.

The synergic combination of Metronidazole plus amoxicillin has been widely and successfully used for the treatment of aggressive and severe chronic periodontitis, demonstrating additional benefits in clinical and microbiological parameters over scaling and root planning alone. However, and despite its proven efficacy, there is a lack of evidence that evaluates the impact of antimicrobials intake at different times of the mechanical treatment, emphasizing the necessity of a study that compares, simultaneously, the variation of the adjunctive antibiotic effects when they are administered in different moments through the periodontal therapy course.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
35 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •a) age of 35 years old or more, b) at least 3 molars in the mouth, c) at least one site in three of the four quadrants with clinical attachment loss ≥ 3mm; d) at least 4 sites in different teeth with probing depth and clinical attachment level ≥ 6mm and bleeding on probing and at least 14 tooth present in the mouth

Exclusion Criteria

  • •a) previous professional root planning; b) systemic/topic antibiotic or antiinflammatory treatment, at least 6 months prior to the initiation of the study; c) immunosuppression or need for antibiotic coverage for routine dental therapy; d) systemic condition that could affect the progression of periodontal disease (diabetes); e) pregnancy or lactation; e) allergy or intolerance to metronidazole or amoxicillin; f) smokers

Arms & Interventions

Scaling and root planning + placebo + antibiotics

Experimental
  • Scaling and root planning + placebo
  • Scaling and root planning + metronidazole plus amoxicillin
  • Metronidazole plus amoxicillin + scaling and root planning

Intervention: Administration of Metronidazole plus Amoxicillin (Drug)

Outcomes

Primary Outcomes

- Mean change in clinical attachment level (CAL)

Time Frame: 12 months

Secondary Outcomes

  • - Mean change in probing pocket depths (PD)(12 months)

Investigators

Sponsor
University of Chile
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jorge Gamonal

Academic

University of Chile

Study Sites (1)

Loading locations...

Similar Trials